ENGRAFTING HUMAN NEURONS INTO ANIMAL MODELS TO STUDY SCHIZOPHRENIA
将人类神经元移植到动物模型中研究精神分裂症
基本信息
- 批准号:9233312
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAddressAffectAmericanAnatomyAnimal ModelAnimalsAntipsychotic AgentsAreaAttentionBiologicalBiological ModelsBrainCell physiologyCellsCellular MorphologyComplexComputing MethodologiesDefectDelusionsDiseaseDisease MarkerDisease modelExhibitsExpressed EmotionFire - disastersFunctional disorderGene TargetingGeneral PopulationGenesGeneticGoalsGrantHallucinationsHealth Care CostsHigh Frequency OscillationHomelessnessHumanIn VitroIndividualLeadLife ExpectancyMembraneMemoryMental disordersMentorsMolecular GeneticsMorphologyMusNeuronsOutputPathologyPatientsPharmacotherapyPhysiologicalPhysiologyPlayPluripotent Stem CellsPopulationPropertyPublic HealthResearchRoleSchizophreniaShapesStem cellsStructureSubstance abuse problemSymptomsSystemTestingThe SunTransplantationbasebiophysical propertiesexcitatory neurongene functionhigh throughput screeninginhibitory neuroninsightnerve stem cellneural circuitneuronal circuitryneuronal patterningnovelnovel therapeuticspsychologicrelating to nervous systemresearch studyresponsesuicidal risktool
项目摘要
Affecting over 1% of the world’s population, including 3 million Americans, schizophrenia is a debilitating
psychiatric disorder characterized by an array of symptoms including hallucinations, delusions, difficulty
expressing emotions, and deficits in attention and memory. Despite the currently available antipsychotics,
patients suffering schizophrenia have a life expectancy 10 years lower than that of the general population, are
prone to substance abuse, homelessness, and are at risk of suicide. As a result, both the toll exacted on the
lives of individuals suffering from the disorder and the public health costs are substantial. There is currently no
cure for schizophrenia, and research into the causes of the disease, including the anatomical and physiological
disruptions in the brain, has been difficult because little is known about the underlying pathology of cells in
patients.
To elucidate the anatomical and physiological deficits found in the patients with schizophrenia, this
proposal will develop a novel model for the disorder by transplanting reprogrammed human inducible
pluripotent stem cells (iPSCs) into an animal system. During the mentored portion of this grant, the anatomical
(Aim 1) and physiological deficits (Aim 2) that occur in neurons derived from patients with schizophrenia will be
characterized. Both aims are underway, and schizophrenia stem cells have been successfully engrafted into
mice. Additionally, novel computational methods for studying the anatomical and physiological complexity of
these cells have been developed. Based on the discoveries made in the first two aims, the independent
portion of this proposal (Aim 3) will relate the anatomical and physiological disruptions identified in individual
cells to the global patterns of neuronal activity that are disrupted in patients.
The proposed studies have the potential to provide fundamental insights into the biological basis of
schizophrenia. The results and tools developed in this project will advance the basic understanding of
neuronal function, and could pave the way for high-throughput assays with which to screen new drug therapies
for the treatment of the disorder.
影响超过1%的世界人口,包括300万美国人,精神分裂症是一种使人衰弱的疾病。
以一系列症状为特征的精神障碍,包括幻觉、妄想、困难
表达情绪,注意力和记忆力的缺陷。尽管目前有抗精神病药物,
患有精神分裂症的患者的预期寿命比一般人群低10年,
有滥用药物、无家可归和自杀风险的倾向。因此,无论是对收费的
患有这种疾病的个人的生命和公共卫生费用是巨大的。目前没有
治疗精神分裂症,并研究疾病的原因,包括解剖和生理
在大脑中的破坏,一直是困难的,因为很少有人知道细胞的基本病理学,
患者
为了阐明精神分裂症患者的解剖和生理缺陷,
一项提案将通过移植重编程的人类诱导型细胞来开发一种新的疾病模型
多能干细胞(iPSC)进入动物系统。在这一补助金的指导部分,解剖
(Aim 1)和生理缺陷(目的2),发生在神经元来源于精神分裂症患者将是
表征了这两个目标都在进行中,精神分裂症干细胞已经成功地移植到
小鼠此外,新的计算方法,研究解剖和生理的复杂性,
这些细胞已经被开发出来。根据前两个目标的发现,独立的
本提案的一部分(目标3)将涉及在个体中识别的解剖学和生理学破坏,
细胞到患者中被破坏的神经元活动的全局模式。
拟议的研究有可能为以下生物学基础提供基本见解:
精神分裂症本项目的成果和开发的工具将促进对以下问题的基本理解:
神经功能,并可能为高通量检测铺平道路,以筛选新的药物疗法
用于治疗疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Krishnan Padmanabhan其他文献
Krishnan Padmanabhan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Krishnan Padmanabhan', 18)}}的其他基金
CRCNS: Linking Synaptic Populations and Computation Using Statistical Mechanics
CRCNS:使用统计力学将突触群体和计算联系起来
- 批准号:
10830119 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
in vivo imaging of transplanted human induced-Pluripotent Stem Cell (iPSC) derived neurons to model neurological and psychiatric disorders
对移植的人类诱导多能干细胞 (iPSC) 衍生的神经元进行体内成像,以模拟神经和精神疾病
- 批准号:
9377090 - 财政年份:2017
- 资助金额:
$ 24.9万 - 项目类别:
in vivo imaging of transplanted human induced-Pluripotent Stem Cell (iPSC) derived neurons to model neurological and psychiatric disorders
对移植的人类诱导多能干细胞 (iPSC) 衍生的神经元进行体内成像,以模拟神经和精神疾病
- 批准号:
9895863 - 财政年份:2017
- 资助金额:
$ 24.9万 - 项目类别:
in vivo imaging of transplanted human induced-Pluripotent Stem Cell (iPSC) derived neurons to model neurological and psychiatric disorders
对移植的人类诱导多能干细胞 (iPSC) 衍生的神经元进行体内成像,以模拟神经和精神疾病
- 批准号:
10132398 - 财政年份:2017
- 资助金额:
$ 24.9万 - 项目类别:
Engrafting human neurons into animal models to study schizophrenia
将人类神经元移植到动物模型中研究精神分裂症
- 批准号:
8727110 - 财政年份:2013
- 资助金额:
$ 24.9万 - 项目类别:
Engrafting human neurons into animal models to study schizophrenia
将人类神经元移植到动物模型中研究精神分裂症
- 批准号:
8568589 - 财政年份:2013
- 资助金额:
$ 24.9万 - 项目类别:
ENGRAFTING HUMAN NEURONS INTO ANIMAL MODELS TO STUDY SCHIZOPHRENIA
将人类神经元移植到动物模型中研究精神分裂症
- 批准号:
9316713 - 财政年份:2013
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant














{{item.name}}会员




